Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy

Annals of Oncology

Volumn 13, Issue 5, 2002, Pages 730-736

  Feliu, J ^a   Calvillo, J ^a   Escribano, A ^a   de Castro, J ^a   Sanchez M E ^a   Mata, A ^a   Espinosa, E ^a   Garcia Grande A ^a   Mateo, A ^a   Gonzalez Baron M ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Leucovorin; Neoadjuvant; Preoperative; Radiotherapy; Rectal carcinoma; UFT

Indexed keywords

FOLINIC ACID; UFT; ANTINEOPLASTIC AGENT; FLUOROURACIL;

ADULT; AGED; ANEMIA; ANUS SPHINCTER; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; DERMATITIS; DIARRHEA; DOSE RESPONSE; DRUG INFUSION; DRUG RESPONSE; FEMALE; HUMAN; MALE; NAUSEA AND VOMITING; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROCTITIS; RECTUM CARCINOMA; RECTUM SURGERY; STOMACH PAIN; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; FOLLOW UP; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; MORTALITY; RADIATION DOSE; RECTUM TUMOR; SURVIVAL;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COMPARATIVE STUDY; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMAN; INFUSIONS, INTRAVENOUS; LEUCOVORIN; MALE; MIDDLE AGE; NEOADJUVANT THERAPY; NEOPLASM STAGING; RADIATION DOSAGE; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; HUMANS; MIDDLE AGED;

EID: 0035985283     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf116     Document Type: Article

References (42)

1. European trials with total mesorectal excision
2. Adjuvant therapy for patients with colon and rectal cancer
3. Controversies in the management of localized rectal cancer. Educational Book
4. Preoperative chemoradiation downstages locally advanced ultrasound-staged rectal cancer
5. Improved surgical results after combining preoperative hyperthermia with chemotherapy and radiotherapy for patients with carcinoma of the rectum
6. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer
7. Treatment systems guidelines for primary rectal cancer from the 1996 patterns of care study
8. Patient preferences for oral versus intravenous palliative chemotherapy
9. A randomized crossover trial comparing oral UFT (uracil/tegafur) + leucovorin (LV) and intravenous fluorouracil (FU) + LV for patient preference and pharmacokinetics in advanced colorectal cancer
10. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2′-tetrahydrofuryl)-5-fluorouracil
11. Effect of excess folates and deoxynosine on the activity and site of action of 5-fluorouracil
12. Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin in combination with fluorouracil in patients with advanced colorectal cancer
13. Phase I study of UFT plus leucovorin in advanced colorectal cancer: A double modulation proposal
14. Efficacy of oral tegafur modulation by uracil (UFT) and leucovorin in advanced colorectal cancer: A phase II study
15. Uracil and tegafur modulated with leucovorin. An effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly
16. UFT-LV as adjuvant therapy for Dukes' B2-C colon cancer
17. Tegafur-uracilo con ácido folínico como tratamiento adyuvante del carcinoma rectal en estadios B2 y C
18. Reporting results of cancer treatment
19. Grading of chemoradiation toxicity
20. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer
21. Sphincter preservation with preoperative radiation therapy and coloanal anastomosis
22. One-sample multiple testing procedure for phase II clinical trials
23. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: The M. D. Anderson Cancer Center experience
24. Preoperative chemoradiotherapy (CT-RDT) in locally advanced rectal cancer. Preliminary results
25. Phase III randomized trial of preoperative versus postoperative multimodality therapy in patients with carcinoma of the rectum (NSABP R-03)
26. Preoperative radiochemotherapy in rectal cancer: Long-term results of a phase II trial
27. Pre-OP combined modality therapy (CMT) for uT3 rectal cancer
28. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: Acute toxicity, tumor response, and sphincter preservation
29. Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: Long term follow-up
30. Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: Acute toxicity, tumor response, sphincter preservation
31. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum
32. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial
33. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation for rectal cancer: Initial results of Intergroup 0114
34. Preoperative 'chemoradiation' for stages II and III rectal carcinoma
35. Concurrent UFT/L-Leucovorin and curative intented radiotherapy (60 Gy) in patients with locally advanced rectal cancer (LARC): A phase I/II trial
36. Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer
37. Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer
38. Pre-operative therapy (PT) with oral uracil and tegafur (UFT) and concomitant irradiation (RT) in operable rectal cancer (RC). Preliminary results of a multicenter phase II study
39. A phase I study of capecitabine combined with radiotherapy for locally advanced potentially operable rectal cancer
40. Phase I study of capecitabine with simultaneous radiotherapy rectal cancer
41. Preoperative combined radiotherapy and chemotherapy for rectal cancer does not affect early postoperative morbidity and mortality in low anterior resection